Hua Medicine Announces 2025 Interim Results Aug 28, 2025 18:07 JST Hua Medicine (the "Company", HKEx: 2552) announced the unaudited consolidated results of the Company and its subsidiaries...
Hua Medicine Announces at 2025 ADA Scientific Sessions that Dorzagliatin Combined with DPP-4 Inhibitor Shows Promise in Reducing Blood Lipids While Restoring Glucose Homeostasis Jun 23, 2025 12:05 HKT/SGT Hua Medicine ("the Company", stock code: 2552.HK <https://2552.HK>) announced today that the Company presented...
Hua Medicine Announces 2024 Annual Results Mar 28, 2025 22:51 JST Hua Medicine ("the Company", Hong Kong Stock Exchange Stock Code: 2552) announced the audited full-year results...
Hua Medicine Announces 2024 Annual Results Mar 28, 2025 21:51 HKT/SGT Hua Medicine ("the Company", Hong Kong Stock Exchange Stock Code: 2552) announced the audited full-year results...
Dr. Li Chen Honored as A Leading Figure in Shanghai's Industry and Commerce Mar 18, 2025 22:36 HKT/SGT On March 17th, the highly anticipated 7th Commendation and Exchange Conference for the Leading Figures in Shanghai's Industry...
